Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115560) titled 'Screening of Early Sepsis Biomarkers Based on Pro-resolving Mediators and the Interventional Study of Salvia miltiorrhiza??' on Dec. 29, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Zhejiang Provincial Hospital of TCM
Condition:
sepsis?spm
Intervention:
Gold Standard:Met the criteria for Sepsis-3?
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Target condition:40;Difficult condition:20
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=293457
Publ...